Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 7—July 2025
Dispatch
Lyme Disease Testing Practices, Wisconsin, USA, 2016–2019
Table 1
Patient characteristics and positivity rates of Lyme disease serologic testing for Lyme disease testing practices, Wisconsin, USA, 2016–2019*
Characteristic | No. (%) test episodes | % Positive (95% CI) |
---|---|---|
Patient sex† | ||
F | 21,656 (51.5) | 5.8 (5.5–6.1) |
M |
20,420 (48.5) |
8.1 (7.7–8.5) |
Patient race/ethnicity | ||
American Indian/Alaska Native | 303 (0.7) | 6.9 (4.6–10.4) |
Asian | 302 (0.7) | 8.6 (6.0–12.3) |
Black or African American | 130 (0.3) | 5.4 (2.6–10.7) |
Native Hawaiian/other Pacific Islander | 28 (0.1) | 7.1 (2.0–22.7) |
White | 37,457 (86.6) | 7.1 (6.8–7.3) |
>1 race | 199 (0.5) | 5.5 (3.1–9.6) |
Hispanic | 623 (1.5) | 5.6 (4.1–7.7) |
Unknown or not reported |
4,035 (9.6) |
5.9 (5.2–6.6) |
Testing month | ||
January | 1,835 (4.4) | 4.6 (3.8–5.7) |
February | 1,563 (3.7) | 4.0 (3.1–5.1) |
March | 1,746 (4.2) | 4.8 (3.9–5.9) |
April | 2,243 (5.3) | 5.1 (4.3–6.1) |
May | 4,215 (10.0) | 5.0 (4.3–5.7) |
June | 6,229 (14.8) | 6.7 (6.1–7.3) |
July | 6,399 (15.2) | 9.6 (8.9–10.4) |
August | 5,306 (12.6) | 9.4 (8.6–10.2) |
September | 3,696 (8.8) | 7.3 (6.5–8.2) |
October | 3,648 (8.7) | 7.2 (6.4–8.1) |
November | 3,022 (7.2) | 5.8 (5.0–6.7) |
December | 2,175 (5.2) | 5.4 (4.5–6.4) |
*Results reflect 42,077 test episodes. †One patient missing data on sex.
Page created: May 09, 2025
Page updated: May 22, 2025
Page reviewed: May 22, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.